Willowbrooke at Tanner

Willowbrooke at Tanner

Services:
Facility Vaping Policy
• Vaping permitted in designated area

Transitional Services

• Aftercare/continuing care
• Discharge Planning
• Naloxone and overdose education
• Outcome follow-up after discharge

Assessment/Pre-treatment

• Outreach to persons in the community
• Interim services for clients
• Comprehensive mental health assessment
• Comprehensive substance use assessment
• Screening for tobacco use
• Screening for substance use
• Screening for mental disorders

Ancillary Services

• Case management service
• Suicide prevention services
• Domestic violence services, including family or partner
• Mental health services
• Transportation assistance
• Social skills development

Facility Smoking Policy

• Smoking permitted in designated area

Recovery Support Services

• Mentoring/peer support

Hospitals

• General Hospital (including VA hospital)

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Age Groups Accepted

• Adults
• Young Adults

Other Services

• Treatment for other addiction disorder

Facility Operation (e.g., Private, Public)

• Private non-profit organization

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity
• Other contracted prescribing entity

Treatment Approaches

• Brief intervention
• Anger management
• Relapse prevention
• Motivational interviewing
• Cognitive behavioral therapy
• Trauma-related counseling
• Telemedicine/telehealth therapy
• Substance use disorder counseling
• Matrix Model

Pharmacotherapies

• Buprenorphine with naloxone
• Non-nicotine smoking/tobacco cessation
• Naltrexone (oral)
• Medication for mental disorders
• Lofexidine
• Acamprosate (Campral®)
• Buprenorphine (extended-release, injectable)
• Naltrexone (extended-release, injectable)
• Clonidine
• Nicotine replacement
• Buprenorphine without naloxone

License/Certification/Accreditation

• The Joint Commission
• Hospital licensing authority

Testing

• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing

Language Services

• Sign language services for the deaf and hard of hearing

External Opioid Medications Source

• No formal relationship with prescribing entity

Special Programs/Groups Offered

• Clients with co-occurring mental and substance use disorders
• Adolescents

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Substance use disorder education
• Hepatitis education, counseling, or support
• Smoking/vaping/tobacco cessation counseling
• Individual counseling
• HIV or AIDS education, counseling, or support
• Group counseling
• Family counseling

Payment/Insurance/Funding Accepted

• Private health insurance
• Medicare
• Cash or self-payment
• Medicaid

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient methadone/buprenorphine or naltrexone treatment
• Intensive outpatient treatment
• Outpatient
• Outpatient day treatment or partial hospitalization
• Regular outpatient treatment

Type of Opioid Treatment

• Prescribes buprenorphine
• Accepts clients using MAT but prescribed elsewhere
• Maintenance service with medically supervised withdrawal after stabilization
• Relapse prevention with naltrexone
• Prescribes naltrexone
• Buprenorphine maintenance

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Gender Accepted

• Female
• Male